ANCA-associated vasculitis with central retinal artery occlusion developing during treatment with methimazole

Intern Med. 2012;51(22):3177-80. doi: 10.2169/internalmedicine.51.8486. Epub 2012 Nov 15.

Abstract

A 63-year-old woman suddenly developed central retinal artery occlusion following a slight fever while being treated with methimazole (MMI) for hyperthyroidism. She was diagnosed to have anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) based on increased inflammatory reactions with positive myeloperoxidase-ANCA in the serum. Her visual acuity remained low despite immediate treatment with corticosteroids and cyclophosphamide after cessation of MMI, which may have played a role in the pathogenesis of AAV. Central retinal artery occlusion is a rare manifestation of AAV; however, it is important with regard to the possibility of serious sequelae.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / diagnosis
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / drug therapy
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / etiology*
  • Anticoagulants / therapeutic use
  • Antithyroid Agents / adverse effects*
  • Dalteparin / therapeutic use
  • Female
  • Humans
  • Hyperthyroidism / drug therapy
  • Immunosuppressive Agents / therapeutic use
  • Methimazole / adverse effects*
  • Middle Aged
  • Retinal Artery Occlusion / diagnosis
  • Retinal Artery Occlusion / drug therapy
  • Retinal Artery Occlusion / etiology*

Substances

  • Anticoagulants
  • Antithyroid Agents
  • Immunosuppressive Agents
  • Methimazole
  • Dalteparin